These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7620190)

  • 1. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
    Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
    Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.
    Sobel JH; Gawinowicz MA
    J Biol Chem; 1996 Aug; 271(32):19288-97. PubMed ID: 8702612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIIIa cross-linking of the Marburg fibrin: formation of alpham.gamman-heteromultimers and the alpha-chain-linked albumin. gamma complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophila.
    Sugo T; Nakamikawa C; Takebe M; Kohno I; Egbring R; Matsuda M
    Blood; 1998 May; 91(9):3282-8. PubMed ID: 9558384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
    Tamaki T; Aoki N
    J Biol Chem; 1982 Dec; 257(24):14767-72. PubMed ID: 6129243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
    Kimura S; Aoki N
    J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP; Lorand L
    J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
    Shainoff JR; Urbanic DA; DiBello PM
    J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
    Wang W
    J Biol Chem; 2011 Dec; 286(52):44952-64. PubMed ID: 22030394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation.
    Collen A; Maas A; Kooistra T; Lupu F; Grimbergen J; Haas FJ; Biesma DH; Koolwijk P; Koopman J; van Hinsbergh VW
    Blood; 2001 Feb; 97(4):973-80. PubMed ID: 11159525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
    Matsuka YV; Medved LV; Migliorini MM; Ingham KC
    Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed intermolecular gamma-chain cross-linking by factor XIIIa in fibrinogen Asahi characterized by a gamma-Met-310 to Thr substitution with an N-glycosylated gamma-Asn-308.
    Yamazumi K; Shimura K; Maekawa H; Muramatsu S; Terukina S; Matsuda M
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):557-9. PubMed ID: 1983463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent crosslinking of von Willebrand factor to fibrin.
    Hada M; Kaminski M; Bockenstedt P; McDonagh J
    Blood; 1986 Jul; 68(1):95-101. PubMed ID: 2872929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function.
    Duval C; Allan P; Connell SD; Ridger VC; Philippou H; Ariëns RA
    Thromb Haemost; 2014 May; 111(5):842-50. PubMed ID: 24430058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.